Date:21/09/11,
Private Equity,
Cross Border Deal,
Symbiotec Pharmalab Ltd, a Madhya Pradesh based company engaged in research, development, manufacturing and marketing of research based APIs for corticosteroids and hormones, receives INR 450 million from Franklin Templeton Private Equity Strategy. Systematix Capital Services Pvt Ltd acted as a advisor to Symbiotec Pharmalab Ltd.
Franklin Templeton Private Equity Strategy was established in 2008 with total capital commitments of INR 6300 million. This fund is managed by Franklin Templeton Asset Management India Pvt Ltd and advised by Darby Asia Investors India Ltd.
No comments:
Post a Comment